Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Long-Term Projected Growth Rate for the Rare Kidney Diseases Market, and What Are the Key Drivers?

The rare kidney diseases market has seen rapid expansion in recent years. It is anticipated to increase from $2.76 billion in 2024 to $3.06 billion in 2025, at a CAGR of 10.6%. Historical growth can be attributed to improved disease recognition, orphan drug designations, heightened patient advocacy and awareness, and global research collaborations.

The rare kidney diseases market is projected to grow significantly, reaching $4.49 billion by 2029 with a CAGR of 10.1%. This growth will be propelled by the rise of gene therapies, increasing investment in rare disease research, enhanced collaboration among stakeholders, and global initiatives for rare disease treatments. Emerging trends include a patient-focused approach, real-world evidence and data analytics, regulatory advancements, the adoption of telemedicine and remote monitoring, and global health initiatives.

Which Major Market Drivers Are Expected to Boost the rare kidney diseases Market’s Growth Potential?

Government support and funding for kidney disorders are expected to boost the growth of the rare kidney disease market. The government invests in kidney health initiatives to improve disease surveillance and patient outcomes. In July 2022, the U.S. House Committee on Appropriations allocated $8.5 million for CDC’s chronic kidney disease program and $1 million for living donation initiatives, totaling $8 million in investments. Thus, government initiatives and funding are driving the rare kidney disease market’s growth.

Request Your Free Rare Kidney Diseases Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample_request?id=11908&type=smp

Which Companies Are Leading the Charge in Expanding the Rare Kidney Diseases Market?

Major companies operating in the rare kidney diseases market include:

• Merck & Co. Inc._x000D_

• Novartis AG_x000D_

• Sanofi S.A_x000D_

• AstraZeneca plc_x000D_

• Otsuka Pharmaceutical Co Ltd._x000D_

What New Trends Are Reshaping the Rare Kidney Diseases Market and Its Opportunities?

Product innovation is a key trend in the rare kidney disease market, with companies developing innovative products to improve their market position. For example, in September 2022, STADA Arzneimittel AG, a Germany-based pharmaceutical company, introduced Kinpeygo (budesonide), the first approved treatment in the EU for immunoglobulin A nephropathy (IgAN), a rare kidney disease. This modified-release capsule is the only approved therapy for primary IgAN in the EU and addresses a significant unmet need for this progressive autoimmune condition.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/rare-kidney-diseases-global-market-report

Which Segments Play a Crucial Role in the Expansion of the Rare Kidney Diseases Market?

The rare kidney diseases market covered in this report is segmented –

1) By Target Indication: IgA Nephropathy, Lupus Nephritis, Focal Segmental Glomerular Sclerosis, Membranous Nephropathy, C3 Glomerulopathy, Other Target Indications

2) By Type Of Molecule: Small Molecules, Biologics

3) By Route Of administration: Oral, Intravenous, Subcutaneous, Other Routes Of Administration

Subsegments:

1) By IgA Nephropathy: Immunosuppressive Therapy, Supportive Care And Symptomatic Management

2) By Lupus Nephritis: Corticosteroids, Antimalarial Agents, Biologics

3) By Focal Segmental Glomerular Sclerosis (FSGS): Corticosteroids, Angiotensin Receptor Blockers (ARBs), Other Immunosuppressive Agents

4) By Membranous Nephropathy: Corticosteroids, Immunosuppressive Therapy, Monoclonal Antibodies

5) By C3 Glomerulopathy: Complement Inhibitors, Supportive Care, Immunosuppressive Therapies

6) By Other Target Indications: Alport Syndrome, Thin Basement Membrane Nephropathy, Other Rare Kidney Disorders

What Are the Top Regions Fueling Growth in the Rare Kidney Diseases Market?

North America was the leading region in the rare kidney disease market in 2024. The regions covered in the rare kidney diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Defines the Scope of the Rare Kidney Diseases Market?

Rare kidney disease is a condition where kidneys are not functioning correctly, waste accumulates in the body, and causes problems with your health. It is a set of renal diseases that have a low frequency in the general population, and these disorders frequently have a genetic or hereditary origin.

Browse Through More Similar Reports By The Business Research Company:

Veterinary Antibiotics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-antibiotics-global-market-report

Veterinary Anti-infectives Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-anti-infectives-global-market-report

Veterinary Healthcare Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-healthcare-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: